CN105441436A - Individualized medication detection kit for receptor blocker - Google Patents

Individualized medication detection kit for receptor blocker Download PDF

Info

Publication number
CN105441436A
CN105441436A CN201510654845.7A CN201510654845A CN105441436A CN 105441436 A CN105441436 A CN 105441436A CN 201510654845 A CN201510654845 A CN 201510654845A CN 105441436 A CN105441436 A CN 105441436A
Authority
CN
China
Prior art keywords
reaction system
reaction
seqidno
primer
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510654845.7A
Other languages
Chinese (zh)
Other versions
CN105441436B (en
Inventor
汪大为
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Jinqi Biotechnology Co Ltd
Original Assignee
Beijing Jinqi Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Jinqi Biotechnology Co Ltd filed Critical Beijing Jinqi Biotechnology Co Ltd
Priority to CN201510654845.7A priority Critical patent/CN105441436B/en
Publication of CN105441436A publication Critical patent/CN105441436A/en
Application granted granted Critical
Publication of CN105441436B publication Critical patent/CN105441436B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of biological detection, and in particular relates to an individualized medication detection kit for a receptor blocker. A detection primer group comprises a positive direction outer side primer F3: SEQ ID NO:1, a negative position outer side primer B3: SEQ ID NO:2, a positive direction inner side primer FIP: SEQ ID NO:3, a negative direction inner side primer BIPC: SEQ ID NO:4 and a negative direction inner side primer BIPG: SEQ ID NO:5. The detection kit provided by the invention is simple in step, quick in response, efficient, high in specificity and simple and convenient in identification, so that the detection kit has a broader application prospect.

Description

A kind of personalized medicine detection kit of beta blocker
Technical field
The invention belongs to technical field of biological, relate to a kind of personalized medicine detection kit of beta blocker, be specifically related to a kind of detection kit of ADRB1 gene pleiomorphism and the reaction system of formation thereof.
Background technology
The subfamily that beta-2 adrenoceptor (β-adrenergicreceptor) is adrenoceptor, belongs to g protein coupled receptor superfamily, comprises β 1, β 2 and β 3 three kinds of different subtypes.This receptoroid is by regulating cAMP and L-type Ca in cell with Gs albumen coupling 2+the open frequency of passage is the action target spot of beta receptor agonist and beta-blockers.The appearance of ADRB1Gly389Arg (rs1801253) pleomorphism site, the generation of Arg389 and Gly389 two type acceptor can be caused, and investigators have confirmed that Arg389 receptor and G-protein coupling efficiency will apparently higher than Gly389 receptors, if so hyperpietic carries Arg389 homozygote gene, then can obtain curative effect more more obvious than Gly389 receptor type patient to Altace Ramipril metoprolol, therefore CFDA points out in " drug metabolism enzyme and the drug target technique of gene detection guide (try) " to announce for 2015: " after Arg389 homozygote genotype patients with heart failure application carvedilol and Metoprolol in Post, Left Ventricular Ejection Fraction improvement situation is better.Suggestion clinicist carries out ADRB1 polymorphic detection before application β1receptor blocade, and according to its genotype adjustment dosage, to improve curative effect, reduces the generation of untoward reaction.”
The testing product of current ADRB1 gene pleiomorphism mainly applies conventional solid chip, liquid-phase chip and quantitative fluorescent PCR etc., and it is high that these technique means exist cost all in various degree, the defect such as cycle long and false positive rate is high.Therefore, set up a kind of detection flux high, easy and simple to handle and cheap ADRB1 genetic polymorphism detection test kit just becomes very important.Isothermal duplication (LAMP) technology of ring mediation is a kind of isothermal amplification technique that Japanese Scientists proposed in 2000, its principal feature is 6 zone design, 4 special primers for target gene, under the effect of strand displacement archaeal dna polymerase (BstDNApolymerase), carry out constant-temperature amplification, only need within 15-90 minute, can 10 be produced 9-10 10the product of the order of magnitude.Judged the genotype of sample to be tested by the change of direct visual perception system status after reaction terminates, without the need to open pipe, therefore enormously simplify operation steps, effectively can avoid sample cross contamination again simultaneously, and, only need ortho-water bath to carry out detection, again save a large amount of testing costs.
Summary of the invention
The present invention, in order to overcome the defect of aforesaid method, provides a kind of personalized medicine detection kit of beta blocker, has that susceptibility is high, specificity good and the advantage such as easy and simple to handle.
For reach this invention object, the present invention by the following technical solutions:
First aspect, a kind of personalized medicine detection kit of beta blocker, described test kit comprises detection primer sets, and described detection primer sets is as follows:
Forward Outside primer F3:SEQIDNO:1:GCCAACGTGGTGAAGGC;
Reverse Outside primer B3:SEQIDNO:2:AGACAGCCCGAGGCG;
Forward inner primer FIP:SEQIDNO:3:TTGGCGTAGCCCAGCCAGACCGCGAGCTGGTGC;
Reverse inner primer BIPC:SEQIDNO:4:CGTCTGCTCTGCTGCGCGGGCCGGTCTCCGTGG;
Reverse inner primer BIPT:SEQIDNO:5:GGTCTGCTCTGCTGCGCGGGCCGGTCTCCGTGG.
Preferably, the sequence shown in described SEQIDNO:1-4 is the C allelotrope for detecting rs1801253 site.
Preferably, the sequence shown in described SEQIDNO:1-3 and SEQIDNO:5 is the G allelotrope for detecting rs1801253 site.
In the present invention, the Outside primer of 4 primers is designated as forward Outside primer F3 and reverse Outside primer B3, and inner primer is designated as forward inner primer FIP and reverse inner primer BIP, and wherein FIP contains F1c and F2, and BIP contains B1c and B2.The present invention, on the basis of common LAMP, with 5 ' of the strictest F1c or B1c of specific requirements end for rs1801253 site design allele specific primer, detects the C allelotrope of rs1801253 and the G allelotrope of rs1801253 respectively.Introduce extra sudden change by the 3rd, the 5 ' end respectively at BIPC and BIPG, reduce the possibility of non-specific amplification further.
Preferably, described reaction system also comprises reaction buffer, dNTPs, hydroxynaphthol blue, trimethyl-glycine, BstDNA polysaccharase, measuring samples genomic dna and deionized water.
Preferably, described reaction buffer comprises Tris-HCl, KCl, (NH 4) 2sO 4, MgSO 4and Tween-20.
Second aspect, the invention provides the detection reaction system that detection kit as described in relation to the first aspect builds, described reaction system comprises the primer sets described in first aspect, reaction buffer, dNTPs, hydroxynaphthol blue, trimethyl-glycine, BstDNA polysaccharase, measuring samples genomic dna and deionized water.
Preferably, described reaction buffer comprises Tris-HCl, KCl, (NH 4) 2sO 4, MgSO 4and Tween-20.
Preferably, the concentration of described Tris-HCl is 10-30mM, can be such as 10mM, 11mM, 12mM, 13mM, 15mM, 16mM, 18mM, 20mM, 22mM, 23mM, 25mM, 26mM, 28mM or 30mM, be preferably 15-25mM, more preferably 20mM.
Preferably, the concentration of described KCl is 10-60mM, can be such as 10mM, 11mM, 12mM, 15mM, 20mM, 25mM, 30mM, 35mM, 40mM, 45mM, 46mM, 48mM, 50mM, 51mM, 52mM, 53mM, 55mM, 56mM, 57mM, 58mM, 59mM or 60mM, be preferably 50-55mM, more preferably 50mM.
Preferably, described (NH 4) 2sO 4concentration be 5-13mM, can be such as 5mM, 6mM, 7mM, 8mM, 9mM, 10mM, 11mM, 12mM or 13mM, be preferably 8-12mM, more preferably 10mM.
Preferably, described MgSO 4concentration be 2-8mM, can be such as 2mM, 3mM, 4mM, 5mM, 6mM, 7mM or 8mM, be preferably 2-6mM, more preferably 4mM.
Preferably, the volume fraction of described Tween-20 is 0.1-1%, such as, can be 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1%, is preferably 0.1%.
Preferably, the concentration of described dNTPs is 1-2mM, such as, can be 1mM, 1.1mM, 1.2mM, 1.3mM, 1.4mM, 1.5mM, 1.6mM, 1.7mM, 1.8mM, 1.9mM or 2mM, is preferably 1.2-1.8mM, more preferably 1.4mM.
Preferably, the concentration of described hydroxynaphthol blue is 108-130 μM, it can be such as 108 μMs, 109 μMs, 110 μMs, 111 μMs, 112 μMs, 115 μMs, 116 μMs, 118 μMs, 120 μMs, 122 μMs, 125 μMs, 126 μMs, 128 μMs or 130 μMs, be preferably 115-123 μM, more preferably 120 μMs.
Preferably, described beet paper mill wastewater is 0-1M, such as, can be 0M, 0.2M, 0.4M, 0.5M, 0.6M, 0.7M, 0.8M, 0.9M or 1M, is preferably 0.5-0.8M, more preferably 0.8M.
As optimal technical scheme, described reaction system comprises reaction system C and reaction system G, and wherein each 25 μ L reaction systems contain following component:
Damping fluid:
The third aspect, the invention provides a kind of using method of the reaction system as described in second aspect, described method comprises the steps:
By complete for component mixing each needed for reaction system C and reaction system G, be positioned over thermostat water bath and react, heat up after reaction and carries out inactivation treatment, then according to system colour-change result of determination.
Preferably, the temperature of described thermostat water bath is 55-70 DEG C, such as, can be 55 DEG C, 56 DEG C, 57 DEG C, 58 DEG C, 59 DEG C, 60 DEG C, 61 DEG C, 62 DEG C, 63 DEG C, 64 DEG C, 65 DEG C, 68 DEG C or 70 DEG C, is preferably 58-61 DEG C, more preferably 60 DEG C.
Preferably, the described reaction times is 15-90min, can be such as 15min, 16min, 18min, 20min, 25min, 30min, 35min, 40min, 45min, 50min, 51min, 52min, 53min, 55min, 56min, 58min, 60min, 61min, 62min, 64min, 65min, 70min, 75min, 80min, 85min or 90min, be preferably 55-62min, more preferably 60min.
Preferably, describedly according to system colour-change result of determination be:
Reaction system C is sky blue, and reaction system G is violet, then loci gene type to be measured is CC;
Reaction system C is violet, and reaction system G is sky blue, then loci gene type to be measured is GG;
Reaction system C is sky blue, and reaction system G is sky blue, then loci gene type to be measured is CG.
Compared with prior art, the present invention has following beneficial effect:
(1) test kit step of the present invention is simple: DNA amplification is placed in thermostat water bath after only needing reaction system to configure carries out reacting, and does not need the sex change carrying out double-stranded DNA in advance and the alternating temperature process such as sex change repeatedly, annealing, extension be similar in PCR circulating reaction;
(2) test kit high specific of the present invention: six regions of applying four primer identifying purpose fragments, and the order in these six regions, length, annealing temperature have corresponding requirements, specificity is very high, can according to whether react just can judge target gene existence whether, can be applicable to the somatotype qualitative detection of the similar bacterium of genetic background or virus;
(3) test kit reaction of the present invention fast, efficiently: whole reaction 1h can complete, and productive rate is high;
(4) test kit qualification of the present invention is easy: get final product result of determination by visual color change after having reacted, the observation of result can depart from operational requirement and the instrument restriction of gel imaging, add that reaction is that isothermal carries out, the circulating temperature change that need not rely on PCR instrument complexity has come, just can carry out in water-bath, make this detection kit have more wide application prospect.
Accompanying drawing explanation
Fig. 1 is the schematic diagram of test kit primer sets of the present invention;
Fig. 2 is the schematic diagram of FIP and BIP in test kit primer sets of the present invention;
Fig. 3 is the electrophorogram of the reaction product of M1-4 in the embodiment of the present invention 1;
Wherein, M-DNAmarker, causes down from above and is followed successively by 2400bp, 2200bp, 2000bp, 1800b, 1600bp, 1400bp, 1200bp, 1000bp, 800bp, 600bp, 400bp and 200bp; 1 cthe C reaction system of-M1 group; 1 gthe G reaction system of-M1 group; 2 cthe C reaction system of-M2 group; 2 gthe G reaction system of-M2 group; 3 cthe C reaction system of-M3 group; 3 gthe G reaction system of-M3 group; 4 cthe C reaction system of-M4 group; 4 gthe G reaction system of-M4 group;
Fig. 4 is the Sequencing chromatogram of M1 group in the embodiment of the present invention 1;
Fig. 5 is the Sequencing chromatogram of M2 group in the embodiment of the present invention 1;
Fig. 6 is the Sequencing chromatogram of M3 group in the embodiment of the present invention 1;
Fig. 7 is the Sequencing chromatogram of M4 group in the embodiment of the present invention 1.
Embodiment
For further setting forth the technique means and effect thereof that the present invention takes, further illustrate technical scheme of the present invention below in conjunction with the preferred embodiments of the present invention, but the present invention is not confined in scope of embodiments.
Unreceipted concrete technology or condition person in embodiment, according to the technology described by the document in this area or condition, or carry out according to product description.Agents useful for same or the unreceipted production firm person of instrument, be by the commercially available conventional products of regular channel.
Embodiment
Extract 4 people 1ml venous blood to preserve with EDTA anticoagulant tube, often 200ul blood got by pipe, and by the DNA extraction kit of full formula gold or other company, reference reagent box specification sheets extracts complete genome DNA as the template detected, and is labeled as M1, M2, M3 and M4 respectively.Carry out detection reaction with the test kit in the present invention, verify the implementation result of test kit of the present invention.
Allele-SpecificLAMP technology is adopted to template M, makes nucleic acid to be detected carry out LAMP reaction, be divided into two group reaction systems, one group for the allelic system C of C, one group for the allelic system G of G.Template Mn (n is group numbering, 1-4) is joined in system C and system G respectively, obtains reaction system C and G.
First, select the sequence of the primer sets as described in the application's first aspect to sample to react, described primer sets is as follows:
Forward Outside primer F3:SEQIDNO:1:GCCAACGTGGTGAAGGC;
Reverse Outside primer B3:SEQIDNO:2:AGACAGCCCGAGGCG;
Forward inner primer FIP:SEQIDNO:3:TTGGCGTAGCCCAGCCAGACCGCGAGCTGGTGC;
Reverse inner primer BIPC:SEQIDNO:4:CGTCTGCTCTGCTGCGCGGGCCGGTCTCCGTGG;
Reverse inner primer BIPT:SEQIDNO:5:GGTCTGCTCTGCTGCGCGGGCCGGTCTCCGTGG.
Institute responds and all arranges same reaction system, composed as follows:
Reaction system C:
Reaction system G:
During two reaction system reactions, at 60 DEG C, react 60min, be warming up to 80 DEG C afterwards and keep 20min to carry out inactivation treatment, lower the temperature afterwards, observe system colour-change.
Reaction is carried out according to above-mentioned detection method, and before reaction, system color is pansy, and after reaction, color and the genotype of each group reaction system judge as shown in table 1:
Table 1
As can be seen from Table 1, the reaction system C of M1-M4 all becomes sky blue, and the equal nondiscoloration of sample M1, M2 and M4 reaction system G, illustrate that these three samples do not have G allelotrope at rs1801253 place, namely the rs1801253 place of M1, M2 and M4 sample is that CC is homozygous; Sample M3 not only C system becomes sky blue, and G system also becomes sky blue simultaneously, illustrates that M3 is CG heterozygous at rs1801253 place.
For the accuracy of further confirmatory reaction, electrophoresis is carried out to the LAMP product of above-mentioned group, with the agarose gel electrophoresis qualification of 2%, electrophoresis 30min under 6v/cm voltage.The electrophorogram obtained as shown in Figure 3.The reaction system C of M1, M2 and M4 group presents typical scalariform band.Reaction system G does not then have band.M3 group reaction system C and G presents typical scalariform band, with coming to the same thing of detection method of the present invention.
Above-mentioned 4 other templates of experimental group are carried out somatotype by PCR-sequencing respectively, the Sequencing chromatogram obtained as shown in figs. 4-7, contrast gene sequencing collection of illustrative plates and the detected result of detection primer provided by the invention and composition known, the two detection coincide rate 100%.Can verify that result of the present invention is accurate.
In sum, test kit of the present invention can judge the genotype of reacting sample accurately, and test kit step of the present invention is simple: DNA amplification is placed in thermostat water bath after only needing reaction system to configure carries out reacting, and does not need the sex change carrying out double-stranded DNA in advance and the alternating temperature process such as sex change repeatedly, annealing, extension be similar in PCR circulating reaction; Reaction fast, efficient, specificity is high: whole reaction 1h can complete, and productive rate is high; Identify easy: after having reacted, get final product result of determination by visual color change, the visible observation of result can depart from operational requirement and the instrument restriction of gel imaging, add that expanding reaction is that isothermal carries out, the circulating temperature change that need not rely on PCR instrument complexity has come, just can carry out in water-bath, make this detection kit have more wide application prospect.
Applicant states, the present invention illustrates method detailed of the present invention by above-described embodiment, but the present invention is not limited to above-mentioned method detailed, does not namely mean that the present invention must rely on above-mentioned method detailed and could implement.Person of ordinary skill in the field should understand, any improvement in the present invention, to equivalence replacement and the interpolation of ancillary component, the concrete way choice etc. of each raw material of product of the present invention, all drops within protection scope of the present invention and open scope.

Claims (10)

1. a personalized medicine detection kit for beta blocker, is characterized in that, described test kit comprises detection primer sets, and described detection primer sets is as follows:
Forward Outside primer F3:SEQIDNO:1;
Reverse Outside primer B3:SEQIDNO:2;
Forward inner primer FIP:SEQIDNO:3;
Reverse inner primer BIPC:SEQIDNO:4;
Reverse inner primer BIPG:SEQIDNO:5.
2. detection kit according to claim 1, is characterized in that, the sequence shown in described SEQIDNO:1-4 is the C allelotrope for detecting rs1801253 site;
Preferably, the sequence shown in described SEQIDNO:1-3 and SEQIDNO:5 is the G allelotrope for detecting rs1801253 site.
3. detection kit according to claim 1 and 2, is characterized in that, described test kit also comprises reaction buffer, dNTPs, hydroxynaphthol blue, trimethyl-glycine, BstDNA polysaccharase, measuring samples genomic dna and deionized water.
Preferably, described reaction buffer comprises Tris-HCl, KCl, (NH 4) 2sO 4, MgSO 4and Tween-20.
4. the detection reaction system of the detection kit structure according to any one of claim 1-3, it is characterized in that, described reaction system comprises: the primer sets described in claim 1 or 2, reaction buffer, dNTPs, hydroxynaphthol blue, trimethyl-glycine, BstDNA polysaccharase, measuring samples genomic dna and deionized water.
5. reaction system according to claim 4, is characterized in that, described reaction buffer comprises Tris-HCl, KCl, (NH 4) 2sO 4, MgSO 4and Tween-20;
Preferably, the concentration of described Tris-HCl is 10-30mM, is preferably 15-25mM, more preferably 20mM;
Preferably, the concentration of described KCl is 10-60mM, is preferably 50-55mM, more preferably 50mM;
Preferably, described (NH 4) 2sO 4concentration be 5-13mM, be preferably 8-12mM, more preferably 10mM;
Preferably, described MgSO 4concentration be 2-8mM, be preferably 2-6mM, more preferably 4mM;
Preferably, the volume fraction of described Tween-20 is 0.1-1%, is preferably 0.1%.
6. the reaction system according to any one of claim 4 or 5, is characterized in that, the concentration of described dNTPs is 1-2mM, is preferably 1.2-1.8mM, more preferably 1.4mM;
Preferably, the concentration of described hydroxynaphthol blue is 108-130 μM, is preferably 115-123 μM, more preferably 120 μMs;
Preferably, described beet paper mill wastewater is 0-1M, is preferably 0.5-0.8M, more preferably 0.8M.
7. the reaction system according to any one of claim 4-6, is characterized in that, described reaction system comprises reaction system C and reaction system G, and wherein each 25 μ L reaction systems contain following component:
Damping fluid:
Deionized water adds to 25 μ L.
8., as a using method for the reaction system according to any one of claim 4-7, it is characterized in that, described method comprises the steps:
By complete for component mixing each needed for reaction system C and reaction system G, be positioned over thermostat water bath and react, heat up after reaction and carries out inactivation treatment, then according to system colour-change result of determination.
9. using method according to claim 8, is characterized in that, the temperature of described thermostat water bath is 55-70 DEG C, is preferably 58-61 DEG C, more preferably 60 DEG C;
Preferably, the described reaction times is 15-90min, is preferably 55-62min, more preferably 60min.
10. using method according to claim 8 or claim 9, is characterized in that, describedly according to system colour-change result of determination is:
Reaction system C is sky blue, and reaction system G is violet, then loci gene type to be measured is CC;
Reaction system C is violet, and reaction system G is sky blue, then loci gene type to be measured is GG;
Reaction system C is sky blue, and reaction system G is sky blue, then loci gene type to be measured is CG.
CN201510654845.7A 2015-10-10 2015-10-10 A kind of personalized medicine detection kit of beta blocker Active CN105441436B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510654845.7A CN105441436B (en) 2015-10-10 2015-10-10 A kind of personalized medicine detection kit of beta blocker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510654845.7A CN105441436B (en) 2015-10-10 2015-10-10 A kind of personalized medicine detection kit of beta blocker

Publications (2)

Publication Number Publication Date
CN105441436A true CN105441436A (en) 2016-03-30
CN105441436B CN105441436B (en) 2019-01-11

Family

ID=55552069

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510654845.7A Active CN105441436B (en) 2015-10-10 2015-10-10 A kind of personalized medicine detection kit of beta blocker

Country Status (1)

Country Link
CN (1) CN105441436B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002071070A2 (en) * 2001-02-13 2002-09-12 University Of Florida β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY
CN102021238A (en) * 2010-06-08 2011-04-20 广州益善生物技术有限公司 ADRB1 (adrenergic, beta-1) gene SNP (Single Nucleotide Polymorphism) detection specificity primer and liquid phase chip
CN102242197A (en) * 2011-05-19 2011-11-16 中国人民解放军疾病预防控制所 LAMP (loop-mediated isothermal amplification) kit and special primers thereof for detecting NDM-1 (new Delhi metallo-beta-lactamase 1) gene
CN102876785A (en) * 2012-09-13 2013-01-16 周宏灏 Kit for detecting beta 1 receptor gene polymorphism by pyro-sequencing method and method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002071070A2 (en) * 2001-02-13 2002-09-12 University Of Florida β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY
CN102021238A (en) * 2010-06-08 2011-04-20 广州益善生物技术有限公司 ADRB1 (adrenergic, beta-1) gene SNP (Single Nucleotide Polymorphism) detection specificity primer and liquid phase chip
CN102242197A (en) * 2011-05-19 2011-11-16 中国人民解放军疾病预防控制所 LAMP (loop-mediated isothermal amplification) kit and special primers thereof for detecting NDM-1 (new Delhi metallo-beta-lactamase 1) gene
CN102876785A (en) * 2012-09-13 2013-01-16 周宏灏 Kit for detecting beta 1 receptor gene polymorphism by pyro-sequencing method and method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATHANASE BADOLO: "Development of an allele-specific, loop-mediated, isothermal amplification method (AS-LAMP) to detect the L1014F kdr-w mutation in Anopheles gambiae s. l.", 《MALARIA JOURNAL》 *
刘威等: "基于颜色判定的环介导恒温扩增快速检测副溶血性弧菌", 《中国科学:生命科学》 *

Also Published As

Publication number Publication date
CN105441436B (en) 2019-01-11

Similar Documents

Publication Publication Date Title
CN1253582C (en) Method for producing complex DNA methylation fingerprints
CN103045591B (en) HLA gene specific PCR amplification primer, HLA typing method and kit
CN102618624A (en) Kit for screening deaf gene of Chinese populations, and use method thereof
CN103911452A (en) Chinese population deaf gene screening kit and application thereof
CN1116421C (en) Detecting DNA damage measuring DNA repair rates, and monitoring DNA repair enzyme activity
CN109837345B (en) Primer and method for detecting residual DNA of mouse cells
KR20120088891A (en) Methods and kits for the detection of BCR-ABL fusion gene mutant using PNA mediated Real-time PCR clamping
CN101768635B (en) ARMS-PCR method for mtDNA allelic gene typing and point mutation detecting
CN107043821A (en) Primer and detection method for detecting the related SNP site of cutaneum carcinoma neurological susceptibility
CN102399872A (en) Method and kit for detecting mutation of K-ras gene
CN113584147A (en) Gene polymorphism detection kit for guiding medication of psychosis
CN105331692A (en) Primer combination, detecting reagent kit and detecting method used for detecting rs1800497
CN105441436A (en) Individualized medication detection kit for receptor blocker
CN105296615A (en) HLA-B*1502 detection kit
CN105255863B (en) A kind of detection primer and combinations thereof of SLCO1B1 521T > C
CN103013993B (en) The method of primer and this primer Mass Spectrometer Method PIK3CA hotspot mutation
CN105274220A (en) CYP4F2*3 detection primer and detection system thereof
CN105602947B (en) The detection primer group of CYP3A5 gene, its reaction system and application for constituting
CN105400871A (en) Detection primer group for ALDH2 genes, reaction system comprising same and application
CN105463087A (en) BRAF V600E gene detection primer set, reaction system constituted by same and application
CN103740831B (en) Primer combination for guiding application of beta-receptor blocker, multi-gene detection kit and using method thereof
CN108504721A (en) A kind of novel individualized treatment gene tester
KR101136008B1 (en) A ligase-based SNP analysis method using oxanine base-containing ligation fragment and a system for analyzing SNP comprising the fragment
CN105274221A (en) CYP3A5*3 detection kit
CN103333963A (en) EGFR (epidermal growth factor receptor) mutation detection primer group and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant